![]() |
市場調查報告書
商品編碼
1426975
神經刺激設備市場規模 - 依產品(深部腦、胃電、脊髓、薦神經、迷走神經刺激器)、按應用(癲癇、疼痛管理、特發性震顫、尿失禁和大便失禁)及預測,2023 - 2032Neurostimulation Devices Market Size - By Product (Deep Brain, Gastric Electric, Spinal Cord, Sacral Nerve, Vagus Nerve Stimulator), By Application (Epilepsy, Pain Management, Essential Tremor, Urinary & Fecal Incontinence) & Forecast, 2023 - 2032 |
在神經系統疾病盛行率不斷上升和人口老化不斷成長的推動下,神經刺激設備市場預計在 2024 年和 2032 年期間CAGR將超過 12.2%。根據世界中風組織-柳葉刀神經病學委員會的資料,預計到2050年,死於中風的人數將增加50%,達到每年近970萬人。
技術創新和對有效治療方案不斷成長的需求是市場成長的另一個驅動力。神經刺激裝置已成為解決各種神經系統疾病的關鍵解決方案。
整個神經刺激設備市場根據產品、應用和地區進行分類。
預計到2032 年,深部腦部刺激器(DBS) 領域將大幅成長。這項創新技術涉及使用植入設備,為大腦的特定區域提供電刺激,為患有帕金森氏症等神經系統疾病的患者提供緩解。特發性震顫、癲癇。近年來,隨著刺激模式精度和客製化的提高、治療效果的提高和副作用的最小化,取得了重大進展,推動了對深部腦部刺激器的需求。
隨著神經刺激設備成為控制症狀和改善患者生活品質的突破,預計到 2032 年,帕金森氏症領域將在市場上產生大量收入。帕金森氏症的特徵是震顫、僵硬和平衡受損,給受影響的人帶來了巨大的挑戰。神經刺激裝置已被證明可以有效緩解運動症狀並提高帕金森氏症患者的整體健康狀況。隨著該領域研發的不斷進步,帕金森氏症應用中的產品採用率將會增加。
受醫療保健支出增加、有利的報銷政策以及神經系統疾病盛行率上升的推動,到 2032 年,歐洲神經刺激設備市場規模將大幅擴大。支持性的監管環境,加上主要參與者和研究機構之間的合作,正在促進創新並推動先進神經刺激技術的發展,塑造區域市場前景。
Neurostimulation devices market is anticipated to record more than 12.2% CAGR during 2024 and 2032, driven by the increasing prevalence of neurological disorders and a growing aging population. According to the data from A World Stroke Organization - Lancet Neurology Commission, the number of people dying from a stroke is expected to increase by 50%, reaching nearly 9.7 million deaths each year by 2050.
The technological innovations and a rising demand for effective treatment options are another driving force for market growth. Neurostimulation devices have emerged as a pivotal solution in addressing various neurological conditions.
The overall neurostimulation devices market is classified based on product, application, and region.
The Deep Brain Stimulator (DBS) segment is predicted to witness substantial growth through 2032. This innovative technology involves the use of implanted devices that deliver electrical stimulation to specific areas of the brain, offering relief for patients suffering from neurological disorders such as Parkinson's disease, essential tremor, and epilepsy. The significant advancements in recent years, with improved precision and customization of stimulation patterns, enhancing therapeutic outcomes and minimizing side effects are pushing the demand for deep brain stimulators.
The Parkinson's disease segment is expected to generate massive revenues in the market by 2032 as neurostimulation devices have emerged as a breakthrough in managing symptoms and improving the quality of life for patients. Parkinson's disease, characterized by tremors, stiffness, and impaired balance, poses significant challenges for those affected. Neurostimulation devices have proven to be effective in alleviating motor symptoms and enhancing the overall well-being of Parkinson's patients. As R&D in this field continue to advance, there will be increased product adoption in Parkinson's disease applications.
Europe neurostimulation devices market size will expand significantly through 2032, driven by the increasing healthcare expenditure, favorable reimbursement policies, and a rising prevalence of neurological disorders. The supportive regulatory environment, in consort with collaborations between key players and research institutions are fostering innovation and driving the development of advanced neurostimulation technologies, shaping the regional market outlook.